Several medications now calm painful inflammation in the intestines. Diets free of ultraprocessed foods also help ...

In patients with ulcerative colitis, vedolizumab outperformed infliximab as a second-line therapy following failure of ...

According to the National Institutes of Health, between 600,000 and 900,000 Americans have ulcerative colitis, a chronic ...

Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis. Since ...

The trial’s primary objective is to assess PALI-2108’s tolerability, pharmacokinetics and safety in healthy volunteers.

A doctor may treat a person’s liver disease ... may change the drug dosage or discontinue using certain drugs for treating ulcerative colitis if they are causing someone to develop liver problems.

Discover the 7 warning signs of ulcerative colitis, plus breakthrough treatments and management strategies that can transform ...

They could help develop a treatment plan to manage ... According to Crohn’s and Colitis UK, examples may include: taking certain medications, such as aminosalicylates taking iron supplements ...

Ulcerative colitis (UC) is a chronic disease that causes inflammation in the large intestine, affecting between 600,000 and ...

Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis.

Vedolizumab outperforms infliximab in ulcerative colitis patients who fail first-line treatment, achieving better ...